These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32099598)

  • 1. Prevalence and prognostic role of PIK3CA E545K mutation in Iranian colorectal cancer patients.
    Ranjbar R; Mohammadpour S; Torshizi Esfahani A; Namazian S; Yaghob-Taleghani M; Baghaei K; Mortazavi Tabatabaei SA; Pasharavesh L; Nazemalhosseini-Mojarad E
    Gastroenterol Hepatol Bed Bench; 2019; 12(Suppl1):S22-S29. PubMed ID: 32099598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients.
    Chen J; Guo F; Shi X; Zhang L; Zhang A; Jin H; He Y
    BMC Cancer; 2014 Nov; 14():802. PubMed ID: 25367198
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Li AJ; Li HG; Tang EJ; Wu W; Chen Y; Jiang HH; Lin MB; Yin L
    World J Gastroenterol; 2018 Feb; 24(5):631-640. PubMed ID: 29434452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
    Zhao S; Cao Y; Liu SB; Wang XA; Bao RF; Shu YJ; Hu YP; Zhang YJ; Jiang L; Zhang F; Liang HB; Li HF; Ma Q; Xu Y; Wang Z; Zhang YC; Chen L; Zhou J; Liu YB
    J Exp Clin Cancer Res; 2016 Jun; 35(1):97. PubMed ID: 27317099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between the incidence of PIK3CA mutations in breast cancer and histopathological characteristics of the tumor].
    Mendelová A; Jezková E; Zubor P; Holubeková V; Lasabová Z; Plank L; Danko J
    Ceska Gynekol; 2014 Aug; 79(4):283-8. PubMed ID: 25398149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen.
    Ramirez-Ardila DE; Helmijr JC; Look MP; Lurkin I; Ruigrok-Ritstier K; van Laere S; Dirix L; Sweep FC; Span PN; Linn SC; Foekens JA; Sleijfer S; Berns EM; Jansen MP
    Breast Cancer Res Treat; 2013 May; 139(1):39-49. PubMed ID: 23592373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and prognostic analysis of PIK3CA mutation in breast cancer patients in Northwest China.
    Lv W; Du C; Zhang Y; Wu F; Jin Y; Chen X; Liu X; Feng C; Ma X; Zhang S
    Pathol Res Pract; 2022 Oct; 238():154063. PubMed ID: 35994807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: A single-site report.
    Luo Q; Chen D; Fan X; Fu X; Ma T; Chen D
    Transl Oncol; 2020 Dec; 13(12):100874. PubMed ID: 32947236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis.
    Mei ZB; Duan CY; Li CB; Cui L; Ogino S
    Ann Oncol; 2016 Oct; 27(10):1836-48. PubMed ID: 27436848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.
    Arjumand W; Merry CD; Wang C; Saba E; McIntyre JB; Fang S; Kornaga E; Ghatage P; Doll CM; Lees-Miller SP
    Oncotarget; 2016 Dec; 7(50):82424-82439. PubMed ID: 27489350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.
    Palomba G; Doneddu V; Cossu A; Paliogiannis P; Manca A; Casula M; Colombino M; Lanzillo A; Defraia E; Pazzola A; Sanna G; Putzu C; Ortu S; Scartozzi M; Ionta MT; Baldino G; Sarobba G; Capelli F; Sedda T; Virdis L; Barca M; Gramignano G; Budroni M; Tanda F; Palmieri G
    J Transl Med; 2016 Oct; 14(1):292. PubMed ID: 27737711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation-Associated Phenotypic Heterogeneity in Novel and Canonical PIK3CA Helical and Kinase Domain Mutants.
    Ghodsinia AA; Lego JMT; Garcia RL
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.
    Gao XH; Yu GY; Hong YG; Lian W; Chouhan H; Xu Y; Liu LJ; Bai CG; Zhang W
    Int J Clin Oncol; 2019 Feb; 24(2):141-152. PubMed ID: 30612269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer.
    Jiang W; He T; Liu S; Zheng Y; Xiang L; Pei X; Wang Z; Yang H
    J Hematol Oncol; 2018 Dec; 11(1):139. PubMed ID: 30547809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review.
    Liao X; Morikawa T; Lochhead P; Imamura Y; Kuchiba A; Yamauchi M; Nosho K; Qian ZR; Nishihara R; Meyerhardt JA; Fuchs CS; Ogino S
    Clin Cancer Res; 2012 Apr; 18(8):2257-68. PubMed ID: 22357840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of mutation profiling in patients with stage II and III colon cancer.
    Shen Y; Han X; Wang J; Wang S; Yang H; Lu SH; Shi Y
    Sci Rep; 2016 Apr; 6():24310. PubMed ID: 27074743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma.
    Zhang L; Shi L; Zhao X; Wang Y; Yue W
    Onco Targets Ther; 2013; 6():497-502. PubMed ID: 23674897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of PIK3CA Mutations in Plasma DNA of Colorectal Cancer Patients by an Ultra-Sensitive PNA-Mediated PCR.
    Zeng Q; Xie L; Zhou N; Liu M; Song X
    Mol Diagn Ther; 2017 Aug; 21(4):443-451. PubMed ID: 28247181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Spectrum, Tendency and Predictive Value of
    Fu X; Lin H; Fan X; Zhu Y; Wang C; Chen Z; Tan X; Huang J; Cai Y; Huang Y
    Front Oncol; 2021; 11():595675. PubMed ID: 33842311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R.
    Meyer DS; Koren S; Leroy C; Brinkhaus H; Müller U; Klebba I; Müller M; Cardiff RD; Bentires-Alj M
    Oncogenesis; 2013 Sep; 2(9):e74. PubMed ID: 24080956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.